Understanding Infantile Hemangioma
April 29, 2015
“You No Longer Have To Watch and Wait.”
Awareness of Infantile Hemangioma
What could be more frightening than bringing your newborn baby home in perfect health, then noticing a bright red tumor-like growth on your baby’s skin? What’s more frustrating than seeking multiple medical opinions, only to be told “just watch and wait”? Infantile Hemangioma is a common benign growth that affects millions of newborn babies. A small percentage can be dangerous to a child’s health, and many more can leave permanent tissue damage if untreated. Until recently, awareness of Infantile Hemangioma was minimal, and available treatments carried significant side effects. A truly groundbreaking treatment has changed the landscape of Pediatric Dermatology. Leading experts like Dr. Ana Duarte, Founder of the Children’s Skin Center and Head of Dermatology at Miami Children’s Hospital, have called this drug “a true game-changer”. Watch and see how it is changing the lives of families living with Infantile Hemangioma.
BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.
The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.
TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.